Linkedin Facebook Contact with Pharma Industrial India
 

Last edition

July-August, 2025
All magazines
Subscribe to our magazine
autodoc
 
Home › News › Quality / GMP

USFDA inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations

USFDA inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations

Zydus Lifesciences Ltd., announced on 10th July 2023, Monday that the group's manufacturing facility at SEZ-2 located at Pharmez, Ahmedabad, underwent a USFDA inspection from 2nd July to 7th July, 2023. The Pre-Approval Inspection (PAI) closed with nil observations.
 
Read more on:
USFDA Zydus Lifesciences Ltd
More news about: quality / gmp | Published by Sudeep Soparkar | July - 10 - 2023 | 1209

Last news about this category

French Court Orders Sanofi to Pay Euro 177 Million for Anti-Competitive Practices Over Plavix French Court Orders Sanofi to Pay Euro 177 Million for Anti-Competitive Practices Over Plavix
ICMR and CDSCO Release First Set of 39 Standard IVD Evaluation Protocols ICMR and CDSCO Release First Set of 39 Standard IVD Evaluation Protocols
India Now Among Top Global Reporters of Drug Adverse Events, Says DCGI India Now Among Top Global Reporters of Drug Adverse Events, Says DCGI
NATCO Pharma's Kothur Facility Receives FDA EIR with VAI Classification NATCO Pharma's Kothur Facility Receives FDA EIR with VAI Classification
AVITA Medical Receives CE Mark for RECELL GO AVITA Medical Receives CE Mark for RECELL GO
Alembic Pharmaceuticals Receives US FDA Compliance Report for Panelav API Facilities Alembic Pharmaceuticals Receives US FDA Compliance Report for Panelav API Facilities
Dr. Reddy's Biologics Facility in Hyderabad Receives USFDA Form 483 with Five Observations Dr. Reddy's Biologics Facility in Hyderabad Receives USFDA Form 483 with Five Observations
Cohance's Jaggaiahpet API Plant Clears USFDA Inspection with Zero 483 Observations Cohance's Jaggaiahpet API Plant Clears USFDA Inspection with Zero 483 Observations
Sun Pharma Halol Facility Classified OAI by US FDA, Shipments Restricted Sun Pharma Halol Facility Classified OAI by US FDA, Shipments Restricted
Akums's Hormonal Plant Gets EAEU GMP Nod, Expands into Eurasia Akums's Hormonal Plant Gets EAEU GMP Nod, Expands into Eurasia
 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members

Privacy Policy | Cookies Policy